Clinical Trial Update: Study to Evaluate Changes in Limb Fat When Switching From a Thymidine Analogue [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 clinical trial sponsored by Gilead Sciences evaluating changes in limb fat after switching from a thymidine anal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lipodystrophy

Snippet

Sponsor: Gilead Sciences | Conditions: Lipodystrophy | Phase 2 | Status: COMPLETED